Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aurora Cannabis Inc. (ACB) vs Akebia Therapeutics, Inc. (AKBA)

Aurora Cannabis Inc. and Akebia Therapeutics, Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. and Akebia Therapeutics, Inc. are of similar size ($267.8M and $254.7M). Akebia Therapeutics, Inc. grew revenue faster over the last twelve months: 7.52% against −18.2%. Akebia Therapeutics, Inc. has the higher net margin (−13.5% vs −38.1%) and the higher return on invested capital (0.00% vs −5.58%). Across the 18 metrics below, Akebia Therapeutics, Inc. leads on 13 and Aurora Cannabis Inc. on 5.

Valuation

Metric ACB AKBA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.20 1.11 2.25
P/B 0.66 9.70 1.90
Price to free cash flow n/m 6.03 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.96 0.62 2.56
Earnings yield (34.39%) (12.00%) (2.99%)
Free cash flow yield (14.28%) 16.59% 0.00%

Profitability

Metric ACB AKBA Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 79.63% 53.94%
Operating margin (12.13%) (6.90%) 0.00%
Net margin (38.12%) (13.54%) 0.00%
Free cash flow margin (17.19%) 18.38% 0.00%
Return on equity (19.85%) (109.38%) (0.40%)
Return on assets (15.19%) (8.53%) (3.32%)
Return on invested capital (5.58%) 0.00% 0.00%

Growth

Metric ACB AKBA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 7.52% 10.01%
EPS growth (last fiscal year) (5,266.67%) 93.94% —
Revenue growth, 5-year CAGR 3.92% (4.33%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB AKBA Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 1.98 0.05
Current ratio 5.36 1.43 2.31
Net debt to EBITDA 5.11 (5.51) 0.85

Dividend

Metric ACB AKBA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ACB AKBA Drug Manufacturers Specialty & Generic median
Market cap 267.79m 254.66m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack